Abstract
Background: Airway remodeling is one of the reasons for severe steroidresistant asthma related to HMGB1/RAGE signaling or Th17 immunity.
Objective: Our study aims to investigate the relationship between the HMGB1/RAGE signaling and the Th17/IL-17 signaling in epithelial-mesenchymal transformation (EMT) of airway remodeling.
Methods: CD4+ T lymphocytes were collected from C57 mice. CD4+ T cell and Th17 cell ratio was analyzed by flow cytometry. IL-17 level was detected by ELISA. The Ecadherin and α-SMA were analyzed by RT-qPCR and immunohistochemistry. The Ecadherin, α-SMA, and p-Smad3 expression were analyzed by western blot.
Results: The HMGB1/RAGE signaling promoted the differentiation and maturation of Th17 cells in a dose-dependent manner in vitro. The HMGB1/RAGE signaling also promoted the occurrence of bronchial EMT. The EMT of bronchial epithelial cells was promoted by Th17/IL-17 and the HMGB1 treatment in a synergic manner. Silencing of RAGE reduced the signaling transduction of HMGB1 and progression of bronchial EMT.
Conclusion: HMGB1/RAGE signaling synergistically enhanced TGF-β1-induced bronchial EMT by promoting the differentiation of Th17 cells and the secretion of IL-17.
[http://dx.doi.org/10.1097/ACI.0b013e32834ec6eb] [PMID: 22217512]
[http://dx.doi.org/10.1164/rccm.200811-1730OC] [PMID: 19406982]
[http://dx.doi.org/10.1002/jcp.22448] [PMID: 20945383]
[http://dx.doi.org/10.1155/2010/318029] [PMID: 20808979]
[http://dx.doi.org/10.1097/ACI.0b013e32833363b2] [PMID: 19858714]
[http://dx.doi.org/10.3342/ceo.2015.8.2.123] [PMID: 26045910]
[http://dx.doi.org/10.1016/j.jaci.2013.12.1035] [PMID: 24506934]
[http://dx.doi.org/10.1146/annurev-med-041316-085215] [PMID: 29106804]
[http://dx.doi.org/10.1016/j.cellsig.2013.06.013] [PMID: 23838007]
[http://dx.doi.org/10.1002/hep.20045] [PMID: 14767995]
[http://dx.doi.org/10.1038/ng.501] [PMID: 20010834]
[http://dx.doi.org/10.3892/ijmm.2016.2474] [PMID: 26847839]
[http://dx.doi.org/10.1126/scitranslmed.aab3142] [PMID: 26290411]
[http://dx.doi.org/10.3389/falgy.2022.806391] [PMID: 35386663]
[http://dx.doi.org/10.1186/s13223-019-0340-7] [PMID: 31168303]
[PMID: 23923066]
[http://dx.doi.org/10.1111/j.1365-3083.2012.02759.x] [PMID: 22809173]
[http://dx.doi.org/10.1016/j.molimm.2018.02.014] [PMID: 29567318]
[PMID: 26623095]
[PMID: 36932919]
[http://dx.doi.org/10.1038/cmi.2014.60] [PMID: 25152078]
[http://dx.doi.org/10.1111/j.1365-2362.2011.02598.x] [PMID: 21950682]
[http://dx.doi.org/10.5847/wjem.j.issn.1920-8642.2012.03.001] [PMID: 25215057]
[http://dx.doi.org/10.1111/febs.12549] [PMID: 24112622]
[PMID: 22761187]
[PMID: 10673212]
[http://dx.doi.org/10.1007/s11010-015-2396-0] [PMID: 25862459]
[http://dx.doi.org/10.1164/rccm.200903-0340OC] [PMID: 20133931]
[http://dx.doi.org/10.1126/sciimmunol.abi4613] [PMID: 35302863]
[http://dx.doi.org/10.1083/jcb.200704015] [PMID: 17923528]
[http://dx.doi.org/10.4049/jimmunol.0901490] [PMID: 20530256]
[http://dx.doi.org/10.21037/atm-19-1739] [PMID: 32617294]
[http://dx.doi.org/10.3389/fimmu.2023.1039997] [PMID: 36776857]
[http://dx.doi.org/10.4049/jimmunol.181.6.4272] [PMID: 18768885]
[http://dx.doi.org/10.1038/pr.2013.222] [PMID: 24226635]
[http://dx.doi.org/10.1038/s41598-017-14667-4] [PMID: 29079726]
[http://dx.doi.org/10.1155/2014/257930] [PMID: 24959003]
[http://dx.doi.org/10.1016/j.intimp.2014.11.005] [PMID: 25479722]
[http://dx.doi.org/10.1016/j.mvr.2021.104178] [PMID: 34015275]
[http://dx.doi.org/10.7554/eLife.21199] [PMID: 28099113]
[http://dx.doi.org/10.1007/s10753-017-0560-2] [PMID: 28391514]
[http://dx.doi.org/10.2147/PTT.S190507] [PMID: 30859087]
[http://dx.doi.org/10.1159/000519703] [PMID: 34942624]